These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24164678)

  • 1. Review: iron metabolism and the role of iron in neurodegenerative disorders.
    Hadzhieva M; Kirches E; Mawrin C
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):240-57. PubMed ID: 24164678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders.
    Mena NP; Urrutia PJ; Lourido F; Carrasco CM; Núñez MT
    Mitochondrion; 2015 Mar; 21():92-105. PubMed ID: 25667951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M; Richardson DR
    Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron in neuronal function and dysfunction.
    Salvador GA
    Biofactors; 2010; 36(2):103-10. PubMed ID: 20232345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial iron metabolism and neurodegenerative diseases.
    Cheng R; Dhorajia VV; Kim J; Kim Y
    Neurotoxicology; 2022 Jan; 88():88-101. PubMed ID: 34748789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
    Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friedreich ataxia: the oxidative stress paradox.
    Seznec H; Simon D; Bouton C; Reutenauer L; Hertzog A; Golik P; Procaccio V; Patel M; Drapier JC; Koenig M; Puccio H
    Hum Mol Genet; 2005 Feb; 14(4):463-74. PubMed ID: 15615771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial iron metabolism and its role in neurodegeneration.
    Horowitz MP; Greenamyre JT
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S551-68. PubMed ID: 20463401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial ferritin in neurodegenerative diseases.
    Yang H; Yang M; Guan H; Liu Z; Zhao S; Takeuchi S; Yanagisawa D; Tooyama I
    Neurosci Res; 2013; 77(1-2):1-7. PubMed ID: 23916831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
    Liddell JR
    Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in neurodegenerative disorders.
    Baron M; Kudin AP; Kunz WS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1228-31. PubMed ID: 17956319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial pathophysiology in Friedreich's ataxia.
    González-Cabo P; Palau F
    J Neurochem; 2013 Aug; 126 Suppl 1():53-64. PubMed ID: 23859341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-dependent functions of mitochondria--relation to neurodegeneration.
    Gille G; Reichmann H
    J Neural Transm (Vienna); 2011 Mar; 118(3):349-59. PubMed ID: 21161302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron dysregulation in Friedreich ataxia.
    Wilson RB
    Semin Pediatr Neurol; 2006 Sep; 13(3):166-75. PubMed ID: 17101455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur D; Andersen J
    Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.